Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Other Non-Current Liabilities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 4.22% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 4.22% year-over-year, with the annual reading at $1.3 million for FY2025, 4.22% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.3 million at Harvard Bioscience, down from $1.5 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $2.8 million in Q1 2021, with the low at $418000.0 in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $1.4 million, with a median of $1.4 million recorded in 2025.
  • The sharpest move saw Other Non-Current Liabilities soared 230.39% in 2021, then tumbled 83.53% in 2022.
  • Over 5 years, Other Non-Current Liabilities stood at $486000.0 in 2021, then skyrocketed by 107.0% to $1.0 million in 2022, then soared by 46.72% to $1.5 million in 2023, then fell by 14.97% to $1.3 million in 2024, then increased by 4.22% to $1.3 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $1.3 million, $1.5 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.